BackTable Vascular and Interventional

What makes segmental embolization an effective approach for large liver tumors? Drs. Christopher Beck and Zachary Berman explain how selective, segmental infusion targets the tumor’s feeding vessels while leveraging mechanical interventions, vessel centering, and controlled…

How can you prevent capsular burst and bleeding from liver ablations? Dr. Driss Raissi discusses how he avoids complications using his innovative 'pre-burn' technique. Hestarts his ablations with a low-power, one-minute burn (45-75 watts) to fixate the needle and desiccate the…

A patient presents to the ER with hemoptysis. When is bronchial artery embolization (BAE) the right call, and what can you do to tip the odds of procedural success in your favor? In this episode of the BackTable Podcast, interventional radiologist Dr. Alexander Lam of UCSF…

Dr. Anahita Dua’s Hot Take: Plain old balloon angioplasty (POBA) is the most OVERRATED device in tibial intervention and Deep Venous Arterialization (DVA) is the most UNDERRATED. In this clip from Episode 570 of the Backtable Podcast, Dr. Dua believes POBA’s time in the spotlight…

How can advanced catheter techniques improve outcomes for patients with neuroendocrine tumors (NETs)? For patients with NETs requiring staged bilobar therapy, Drs. Cristopher Beck and Zachary Berman report that microvalve catheters can enhance tumor uptake of Y-90, improving…

Simple and complex CLI procedures are coded for similarly. This is now changing. This week on BackTable, @drcostantino1 welcomes @GokeIRDoc and and revenue cycle management expert Laurie Bouzarelos as they break down new CPT code changes, impacts on the OBL, ASC conversion, "gap…

What happens if we discover laser atherectomy isn’t beneficial overall? The principal investigator of the AMBITION-BTK trial says she has "no fear of that at all." The large amount of preliminary data has shown that it is effective- if that isn’t actually the case, Dr. Dua argues…

Middle Meningeal Artery embolization: where does it fit in the management of chronic subdural hematoma? Between conservative management and the open surgical approach, MMA embo plays an evolving role. Learn from expert Dr. Paul Gullota of @OchsnerHealth as he shares his process…

Why is pressure-enabled drug delivery (PEDD) particularly useful for large cholangiocarcinomas? Drs. Christopher Beck and Zachary Berman touch on how pressure-enabled drug delivery (PEDD) is especially useful when treating large heterogeneous cholangiocarcinomas because it can…

Type II Endoleaks: how do you monitor these patients in clinic, plan your operative approach, and pick your tools? Tune in to learn from Dr. Mattew Givens as he joins @SDhandMD to dive into transarterial, transcaval, and translumbar techniques. He outlines his embolics of choice…

What technologies are on the horizon for vessel prep innovation? Drs. Mathews and Siah preview emerging technologies like laser IVL, drug-coated spikes, and long-length bioresorbable scaffolds. They discuss how these tools could reshape CTLI care and why physician-led research is…

Vessel prep is getting harder, patients are more difficult to treat than ever. Vascular surgeon, Dr. Anahita Dua, wants to put an end to the disagreements through the AMBITION-BTK trial. She has teamed up with Interventional Cardiology and is determined to get definitive answers…

NEW: The 2025 PERT (@PERTConsortium) Annual Symposium gives interventionalists the reins to tackle even the toughest saddle pulmonary embolisms. Hone your skills by joining @TheRealDoctorOs, @Jonathan_PaulMD, and @AaronFrittsMD as they recap their time at the symposium, their…

This week on BackTable: From angio suite to the boardroom, how did Dr. Howard Chrisman hone and expand his skillset to become President and CEO of @NorthwesternMed? Tune in to hear Dr. Chrisman's discussion with @AaronFrittsMD his mentee @SDhandMD as they explore advocating for…

Which catheter delivers the best results for HCC in decompensated cirrhosis? Drs. Chris Beck and Zachary Berman discuss strategic catheter selection. Dr. Berman typically starts with an end-hole catheter to map the tumor, then uses microvalve catheters to enhance tumor necrosis…

Why are Limus-based therpaies gaining momentum in BTK interventions? Drs. Mathews and Siah compare Limus and Paclitaxel, exploring their pharacologic profiles, delivery challenges, and the role of vessel prep in drug uptake .They discuss why past trials may have failed and how…

Welcome to the “Wild West” of Peripheral Artery Disease (PAD). Vascular surgeon, Dr. Anahita Dua, explains why PAD treatment varies so much from provider to provider. Today, patients get a shocking range of care when coming into the hospital for treatment amongst specialties and…

How do you consider acute vs. chronic nature of clot, liver function, history of cirrhosis, and other clinical factors in a case of portal vein thrombosis (PVT)? Learn from expert Dr. Vijay Ramalingam of @BIDMCVIR and his experiences with the Splanchnic Vein Thrombosis…

What are the benefits of personalized dosimetry to treat hepatocellular carcinoma? Drs. Chris Beck and Zachary Berman outline a case in which personalized dosimetry was used to reduce the tumor burden of an invasive hepatocellular carcinoma that had reached the portal vein. They…